1-248295545-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001004692.2(OR2T12):c.34C>A(p.Leu12Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000368 in 1,603,664 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004692.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR2T12 | NM_001004692.2 | c.34C>A | p.Leu12Ile | missense_variant | 3/3 | ENST00000641276.1 | NP_001004692.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR2T12 | ENST00000641276.1 | c.34C>A | p.Leu12Ile | missense_variant | 3/3 | NM_001004692.2 | ENSP00000493000.1 |
Frequencies
GnomAD3 genomes AF: 0.000159 AC: 24AN: 151220Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000493 AC: 11AN: 222984Hom.: 0 AF XY: 0.0000500 AC XY: 6AN XY: 119946
GnomAD4 exome AF: 0.0000241 AC: 35AN: 1452326Hom.: 0 Cov.: 38 AF XY: 0.0000236 AC XY: 17AN XY: 721332
GnomAD4 genome AF: 0.000159 AC: 24AN: 151338Hom.: 0 Cov.: 31 AF XY: 0.000149 AC XY: 11AN XY: 73892
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 18, 2023 | The c.34C>A (p.L12I) alteration is located in exon 1 (coding exon 1) of the OR2T12 gene. This alteration results from a C to A substitution at nucleotide position 34, causing the leucine (L) at amino acid position 12 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at